Skip to Main Content

Author Details

David M Dorfman
Brigham and Women's Hospital and Harvard Medical School
1982
187
51
PMIDPaper TitleJournal TitlePublished Year
37683132Optimization of Advanced Molecular Genetic Testing Utilization in Hematopathology: A Goldilocks Approach to Bone Marrow Testing.JCO Oncol Pract2024
37776247PCNEO, a New Proficiency Testing Program for Flow Cytometric Analysis of Plasma Cell Neoplasms From the College of American Pathologists Diagnostic Immunology and Flow Cytometry Committee.Arch Pathol Lab Med2024
36533670Dysfunctions of innate and adaptive immune tumor microenvironment in Waldenström macroglobulinemia.Int J Cancer2023
36752202Heterogeneity of B cell lymphopoiesis in patients with premalignant and active myeloma.JCI Insight2023
36737429Identification of disease-related aberrantly spliced transcripts in myeloma and strategies to target these alterations by RNA-based therapeutics.Blood Cancer J2023
35082402Combination therapy targeting Erk1/2 and CDK4/6i in relapsed refractory multiple myeloma.Leukemia2022
35614537AML with t(8;16) mimicking acute promyelocytic leukaemia.Int J Lab Hematol2022
35496359Non-Hodgkin lymphoma mimicking acute leukemia: a report of six cases and review of the literature.J Hematop2022
35513704Author Correction: Combination therapy targeting Erk1/2 and CDK4/6i in relapsed refractory multiple myeloma.Leukemia2022
35064930A case of peripheral T-cell lymphoma, NOS, mimicking acute monocytic leukemia.Am J Hematol2022
32886757Participation in the College of American Pathologists Laboratory Accreditation Program Decreases Variability in B-Lymphoblastic Leukemia and Plasma Cell Myeloma Flow Cytometric Minimal Residual Disease Testing: A Follow-up Survey.Arch Pathol Lab Med2021
33751108miR-15a/16-1 deletion in activated B cells promotes plasma cell and mature B-cell neoplasms.Blood2021
34581772Impact of sickle cell trait on morbidity and mortality from SARS-CoV-2 infection.Blood Adv2021
33219376Laboratory Workup of Lymphoma in Adults.Am J Clin Pathol2021
33175094Laboratory Workup of Lymphoma in Adults: Guideline From the American Society for Clinical Pathology and the College of American Pathologists.Arch Pathol Lab Med2021
32241847A case of Epstein Barr virus-related post-transplant lymphoproliferative disorder after haploidentical allogeneic stem cell transplantation using post-transplantation cyclophosphamide.Haematologica2020
30431665Acute myeloid leukemia with minimal differentiation (AML M0) mimicking acute lymphoblastic leukemia.Am J Hematol2019
31530176Evaluation of Antifactor-Xa Heparin Assay and Activated Partial Thromboplastin Time Values in Patients on Therapeutic Continuous Infusion Unfractionated Heparin Therapy.Clin Appl Thromb Hemost2019
31326977Highly differentiated cytotoxic T cells in inclusion body myositis.Brain2019
30715093Utility of a Simple and Robust Flow Cytometry Assay for Rapid Clonality Testing in Mature Peripheral T-Cell Lymphomas.Am J Clin Pathol2019
31004444Pleomorphic mantle cell lymphoma mimicking diffuse large B-cell lymphoma in peripheral blood and bone marrow.Am J Hematol2019
30854558Use of a Blast Dominance-Hematogone Index for the Flow Cytometric Evaluation of Myelodysplastic Syndrome (MDS).Am J Clin Pathol2019
30911135Highly efficient therapeutic gene editing of human hematopoietic stem cells.Nat Med2019
30371509Utility of Combined EZH2, p-ERK1/2, p-STAT, and MYC Expression in the Differential Diagnosis of EZH2-positive Hodgkin Lymphomas and Related Large B-Cell Lymphomas.Am J Surg Pathol2019
27305702Lupus anticoagulant testing using two parallel methods detects additional cases and predicts persistent positivity.Clin Chem Lab Med2018
30043450Highly atypical myeloblasts in acute myeloid leukaemia with myelodysplasia-related changes in a patient with short telomere syndrome.Br J Haematol2018
29789628Targetable vulnerabilities in T- and NK-cell lymphomas identified through preclinical models.Nat Commun2018
29794078Leukemic-phase progression of aleukemic mast cell leukemia.Blood2018
29327713Expression of enhancer of zeste homolog 2 (EZH2) protein in histiocytic and dendritic cell neoplasms with evidence for p-ERK1/2-related, but not MYC- or p-STAT3-related cell signaling.Mod Pathol2018
28850707Ectopic Intrathyroidal Thymic Tissue Mimicking Thyroid Nodules in Children.J Ultrasound Med2018
27919167An unusual case of chronic lymphocytic leukemia/small lymphocytic lymphoma with nodular morphology.Leuk Lymphoma2017
28314380Myocardial Induction of Type 3 Deiodinase in Dilated Cardiomyopathy.Thyroid2017
29128079Clinical Flow Cytometry: State-of-the-Art and New Approaches.Clin Lab Med2017
29128073Mast Cell Disease Assessment by Flow Cytometric Analysis.Clin Lab Med2017
29128066Flow Cytometry of T cells and T-cell Neoplasms.Clin Lab Med2017
29048129Realgar nanoparticles versus ATO arsenic compounds induce in vitro and in vivo activity against multiple myeloma.Br J Haematol2017
28551327T-cell transcription factor GATA-3 is an immunophenotypic marker of acute leukemias with T-cell differentiation.Hum Pathol2017
28575142Flow Cytometric Patterns of CD200 and CD1d Expression Distinguish CD10-Negative, CD5-Negative Mature B-Cell Lymphoproliferative Disorders.Am J Clin Pathol2017
26920676Association of inclusion body myositis with T cell large granular lymphocytic leukaemia.Brain2016
27764795A novel 3D mesenchymal stem cell model of the multiple myeloma bone marrow niche: biologic and clinical applications.Oncotarget2016
27479652FLOCK cluster analysis of plasma cell flow cytometry data predicts bone marrow involvement by plasma cell neoplasia.Leuk Res2016
27479034The Public Repository of Xenografts Enables Discovery and Randomized Phase II-like Trials in Mice.Cancer Cell2016
27578265Flow Cytometry of Nonhematopoietic Neoplasms.Acta Cytol2016
27282353Differential expression of enhancer of zeste homolog 2 (EZH2) protein in small cell and aggressive B-cell non-Hodgkin lymphomas and differential regulation of EZH2 expression by p-ERK1/2 and MYC in aggressive B-cell lymphomas.Mod Pathol2016
26834126Automated Nucleated RBC Measurement Using the Sysmex XE-5000 Hematology Analyzer: Frequency and Clinical Significance of the Nucleated RBCs.Am J Clin Pathol2016
27070704The Public Repository of Xenografts Enables Discovery and Randomized Phase II-like Trials in Mice.Cancer Cell2016
25012943Imatinib mesylate lacks efficacy in relapsed/refractory peripheral T cell lymphoma.Leuk Lymphoma2015
26486741FLOCK cluster analysis of mast cell event clustering by high-sensitivity flow cytometry predicts systemic mastocytosis.Am J Clin Pathol2015
26320100EHMT1 and EHMT2 inhibition induces fetal hemoglobin expression.Blood2015
27148573Complete hematologic response of early T-cell progenitor acute lymphoblastic leukemia to the γ-secretase inhibitor BMS-906024: genetic and epigenetic findings in an outlier case.Cold Spring Harb Mol Case Stud2015
  • 1 - 50 of 187

Recommended Authors

Weill Cornell Medicine and New York Presbyterian Hospital
Career Start Year 2013
Number of shared co-authors 1
The University of Texas MD Anderson Cancer Center
Career Start Year 2011
Number of shared co-authors 0
Yale School of Medicine
Career Start Year 2010
Number of shared co-authors 0
University of Washington
Career Start Year 2010
Number of shared co-authors 1
Oregon Health & Science University
Career Start Year 2008
Number of shared co-authors 0
Children's Hospital of Los Angeles
Career Start Year 2008
Number of shared co-authors 3
Intermountain Medical Center
Career Start Year 2007
Number of shared co-authors 0
Intermountain Medical Center
Career Start Year 2001
Number of shared co-authors 0
University of Virginia Department of Pathology
Career Start Year 2001
Number of shared co-authors 0
Oregon Health and Science University
Career Start Year 2000
Number of shared co-authors 1
Seoul St. Mary's Hospital, The Catholic University of Korea
Career Start Year 1999
Number of shared co-authors 0
Tuen Mun Hospital
Career Start Year 1999
Number of shared co-authors 0
Memorial Sloan Kettering Cancer Center
Career Start Year 1998
Number of shared co-authors 3
School of Clinical Medicine, University of Hong Kong
Career Start Year 1997
Number of shared co-authors 0
The University of Texas MD Anderson Cancer Center
Career Start Year 1996
Number of shared co-authors 8
Scripps Clinic Medical Group
Career Start Year 1995
Number of shared co-authors 0
Johns Hopkins University School of Medicine
Career Start Year 1992
Number of shared co-authors 1
Fred Hutchinson Cancer Research Center
Career Start Year 1989
Number of shared co-authors 1
National Cancer Institute, National Institutes of Health
Career Start Year 1983
Number of shared co-authors 6
University of Utah
Career Start Year 1982
Number of shared co-authors 2
Institute for Biomedical Research August Pi I Sunyer
Career Start Year 1981
Number of shared co-authors 3
National Cancer Institute, National Institutes of Health
Career Start Year 1981
Number of shared co-authors 0
Center for Cancer Research, National Cancer Institute
Career Start Year 1981
Number of shared co-authors 1
University Hospital Essen, University of Duisburg-Essen
Career Start Year 1979
Number of shared co-authors 0
National Cancer Institute, National Institutes of Health
Career Start Year 1979
Number of shared co-authors 2
Lehigh Valley Hospital
Career Start Year 1977
Number of shared co-authors 0
University of California San Diego
Career Start Year 1977
Number of shared co-authors 6
University of Maryland School of Medicine
Career Start Year 1977
Number of shared co-authors 1
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Career Start Year 1972
Number of shared co-authors 4
Sapienza University.
Career Start Year 1968
Number of shared co-authors 7

Collaborators

Boston Children's Hospital and Dana-Farber Cancer Institute, Harvard Medical School
Co-authored papers 11
Dana Farber Cancer Institute
Co-authored papers 10
Dana-Farber Cancer Institute
Co-authored papers 5
Co-authored papers 5
Merck & Co.
Co-authored papers 5
Co-authored papers 4
Meyer Cancer Center, Weill Cornell Medicine and New York Presbyterian Hospital
Co-authored papers 4
Brigham and Women's Hospital Department of Neurology, and Harvard Medical School
Co-authored papers 3
Co-authored papers 3
Co-authored papers 3
Brigham and Women's Hospital and Harvard Medical School
Co-authored papers 3
Dana Farber Cancer Institute
Co-authored papers 3
Novartis Institutes for BioMedical Research
Co-authored papers 3
Dana-Farber Cancer Institute
Co-authored papers 3
Dana-Farber Cancer Institute
Co-authored papers 3
Co-authored papers 2
Dana-Farber Cancer Institute, Harvard Medical School, Brigham and Women's Hospital
Co-authored papers 2
Co-authored papers 2
Co-authored papers 2
Brigham Women's Hospital, Harvard Medical School
Co-authored papers 2
The University of Texas MD Anderson Cancer Center
Co-authored papers 2
Dana-Farber Cancer Institute
Co-authored papers 2
Massachusetts General Hospital
Co-authored papers 2
Co-authored papers 2
Massachusetts General Hospital
Co-authored papers 2
Dana-Farber Cancer Institute
Co-authored papers 2
Co-authored papers 1
Boston Children's Hospital
Co-authored papers 1
Co-authored papers 1
Center for Biologics Evaluation and Research
Co-authored papers 1